Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity
Open Access
- 16 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 12 (7), 1-12
- https://doi.org/10.1038/s41419-021-03922-2
Abstract
Proteasomal activity is compromised in diabetic hearts that contributes to proteotoxic stresses and cardiac dysfunction. Osteocrin (OSTN) acts as a novel exercise-responsive myokine and is implicated in various cardiac diseases. Herein, we aim to investigate the role and underlying molecular basis of OSTN in diabetic cardiomyopathy (DCM). Mice received a single intravenous injection of the cardiotrophic adeno-associated virus serotype 9 to overexpress OSTN in the heart and then were exposed to intraperitoneal injections of streptozotocin (STZ, 50 mg/kg) for consecutive 5 days to generate diabetic models. Neonatal rat cardiomyocytes were isolated and stimulated with high glucose to verify the role of OSTN in vitro. OSTN expression was reduced by protein kinase B/forkhead box O1 dephosphorylation in diabetic hearts, while its overexpression significantly attenuated cardiac injury and dysfunction in mice with STZ treatment. Besides, OSTN incubation prevented, whereas OSTN silence aggravated cardiomyocyte apoptosis and injury upon hyperglycemic stimulation in vitro. Mechanistically, OSTN treatment restored protein kinase G (PKG)-dependent proteasomal function, and PKG or proteasome inhibition abrogated the protective effects of OSTN in vivo and in vitro. Furthermore, OSTN replenishment was sufficient to prevent the progression of pre-established DCM and had synergistic cardioprotection with sildenafil. OSTN protects against DCM via restoring PKG-dependent proteasomal activity and it is a promising therapeutic target to treat DCM.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 75 references indexed in Scilit:
- Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-CalpainJournal of Virology, 2012
- Hyperamylinemia Contributes to Cardiac Dysfunction in Obesity and DiabetesCirculation Research, 2012
- Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in miceJCI Insight, 2011
- Proteasome functional insufficiency activates the calcineurin–NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse heartsCardiovascular Research, 2010
- Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated CardiomyopathiesCirculation, 2010
- Cardiac Muscle Protein Catabolism in Diabetes Mellitus: Activation of the Ubiquitin-Proteasome System by Insulin DeficiencyEndocrinology, 2008
- Foxo1 represses expression of musclin, a skeletal muscle-derived secretory factorBiochemical and Biophysical Research Communications, 2007
- Musclin, a Novel Skeletal Muscle-derived Secretory FactorOnline Journal of Public Health Informatics, 2004
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974
- New type of cardiomyopathy associated with diabetic glomerulosclerosisThe American Journal of Cardiology, 1972